Categories: Updates

Dates for 2022 Conferences Announced

The dates for Binaytara Foundation’s major in-person annual oncology conferences in 2022 have been announced. The Binaytara Foundation will kick-off 2022 with the Highlights from the San Antonio Breast Cancer Symposium (SABCS) on January 29, 2022 at the Grand Hyatt Seattle. Then in February, we will head to our favorite conference venue, the Coeur d’Alene Resort for our annual Highlights from the American Society of Hematology (ASH) 63rd annual Meeting – 2022 Highlights of ASH – on February 19, 2022.

The Binaytara Foundation will also start its mini oncology conference series in Washington, Idaho, Montana, and Utah this coming year. March will feature the inaugural mini oncology conference series in the beautiful Olympic Peninsula – Sequim, Washington. The goal of these mini oncology conferences is to provide quick updates to community oncology providers about new developments in the management of cancer patients in an collegial and intimate environment close to their place of work or home. We will expand these mini conferences to other parts of Washington and neighboring states later in 2022.

April bring our flagship Cancer Disparity conference to Seattle. The 2022 Summit on Cancer Health Disparities (SCHD22) is a 2.5-day conference and will be held at the Grand Hyatt Seattle from April 29, 2022 to May 1, 2022. The SCHD22 is expected to be attended by over 300 participants from the United States and other parts of the world. Abstract submission for the 2022 Summit on Cancer Health Disparities (SCHD22) is open through January 11, 2022. Click here to submit abstracts.

Then in June, we will hold our 10th annual ASCO Review – the ASCO Direct™ Highlights – on June 18-19, 2022 at the Grand Hyatt, Seattle. This officially licensed ASCO review will feature review of practice changing abstracts presented at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting.

Our 2nd Annual Precision Oncology Summit will be held in Salt Lake City, Utah on October 7-8, 2022. Another one of our annual oncology conference being held in October is the Seattle Multidisciplinary Lung Cancer Conference on October 22, 2022 at the Grand Hyatt, Seattle.

All of our educational activities are designed to provide AMA PRA Category I credits™ and Nursing Contact Hours. Successful completion of these CME activities, which includes participation in the evaluation component, and quizzes enables the participants to earn Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. If you missed any of these in-person oncology conferences in 2021, please visit our education website and register free for these activities.

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

7 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

7 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

7 months ago